1. Review current guidelines for treatment of Muscle Invasive Bladder Cancer (MIBC).
2. Discuss clinical evidence of immunotherapy in the adjuvant setting.
3. Discuss current and future investigational approaches with immunotherapy in the neoadjuvant setting.
12/13/2018 - 8:00am to 9:00am CST
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Carolina Soto Chervin, MD, PhD